By yourNEWS Media Newsroom
Comfrey, a medicinal plant traditionally used to treat wounds, broken bones and joint pain, contains naturally occurring compounds associated with tissue repair and inflammation relief. However, medical researchers warn that the herb also contains potentially dangerous toxins that can cause severe liver damage, making the distinction between external and internal use particularly important.
Known scientifically as Symphytum officinale, comfrey is a perennial herb native to Europe and Asia that has spread to other parts of the world. Its long history in herbal medicine earned it names such as “knitbone” and “boneset,” reflecting the traditional belief that it could help mend fractured bones and accelerate recovery from injuries.
The plant contains allantoin, a naturally occurring compound associated with cell proliferation and tissue repair, along with rosmarinic acid, which has demonstrated anti-inflammatory activity in laboratory research. These substances contribute to scientific interest in comfrey’s potential therapeutic properties.
According to the National Institutes of Health’s LiverTox database, comfrey roots and leaves contain several potentially active constituents, including allantoin, rosmarinic acid, tannins, triterpene saponins and silicic acid. Some topical formulations have demonstrated modest pain-relieving effects in human studies involving muscle and joint discomfort.
Comfrey has traditionally been prepared as creams, ointments, salves and poultices for bruises, sprains, muscle soreness, arthritis and skin irritation. Historical applications also included treatment of cuts, wounds and fractures, although modern clinical evidence supporting these uses varies considerably.
The European Medicines Agency recognizes the traditional use of certain comfrey root preparations for relieving symptoms of minor sprains and bruises in adults.
The agency reviewed clinical studies suggesting that specific topical comfrey formulations could reduce swelling and pain. However, because the preparations examined in those trials differed from the product covered by its herbal monograph, the agency based its formal conclusions on longstanding traditional use rather than establishing broad clinical effectiveness.
Other studies have investigated comfrey-based products for osteoarthritis and back pain. While some findings suggest improvements in discomfort and mobility, researchers have cautioned that the evidence remains limited and does not establish that all comfrey preparations are equally effective.
Despite the plant’s reputation for healing, its chemical composition creates important health risks.
Comfrey contains pyrrolizidine alkaloids, commonly abbreviated PAs, which can damage the liver when consumed. These naturally occurring substances can produce toxic metabolites that injure blood vessels within the liver, potentially causing a condition known as hepatic sinusoidal obstruction syndrome.
The disorder interferes with normal blood flow through the liver and can cause abdominal pain, swelling, fluid accumulation, jaundice and, in severe cases, liver failure.
Medical literature has documented cases of serious liver injury following consumption of comfrey teas and other oral preparations. Laboratory animal studies have also raised concerns about the potential carcinogenic effects of certain pyrrolizidine alkaloids.
The Memorial Sloan Kettering Cancer Center’s herbal medicine review warns that comfrey’s traditional reputation does not eliminate the documented risks associated with its consumption.
In 2001, the U.S. Food and Drug Administration advised dietary supplement manufacturers to remove products containing comfrey from the market because of concerns about liver toxicity. Oral comfrey products are not considered safe for medicinal or nutritional use.
Historically, comfrey leaves were occasionally incorporated into soups and herbal teas, while its roots were prepared as infusions and other remedies. Such practices are now discouraged because potentially harmful alkaloids can be present throughout the plant.
The herb’s physical characteristics include large, hairy leaves, thick roots containing mucilaginous substances and clusters of bell-shaped flowers that may appear purple, pink, blue or cream-colored. Its leaves have a mildly bitter taste, although the plant should not be treated as an edible vegetable.
Comfrey also occupies a place in European folklore, where it was associated with protection, healing and general well-being. Some traditional beliefs credited the plant with warding off evil spirits, while herbal practitioners valued its supposed ability to accelerate recovery from physical injuries.
Modern research has shifted attention away from these historical beliefs toward identifying the plant’s biologically active compounds and determining whether their potential benefits can be obtained without exposing patients to toxic alkaloids.
One area of investigation involves processing comfrey extracts to reduce or remove pyrrolizidine alkaloids before incorporating them into topical preparations.
A 2023 study examining the alkaloid content of comfrey roots and leaves found that the concentrations and chemical profiles of these compounds can vary, reinforcing the importance of standardized manufacturing and careful evaluation of herbal products.
The European Medicines Agency limits its recognized traditional use of certain comfrey root medicines to short-term application on intact skin in adults. Its guidance restricts treatment to no more than 10 days and establishes strict limits on exposure to toxic pyrrolizidine alkaloids.
Applying comfrey to broken skin, open wounds or large areas of the body may increase exposure to potentially harmful substances. Prolonged or repeated topical application is also discouraged, particularly when the alkaloid content of a preparation is unknown.
These precautions are especially important for pregnant or breastfeeding women, children, people with liver disease and individuals taking medications that may affect liver function.
The NIH’s Drugs and Lactation Database advises against comfrey use during breastfeeding because of its potentially toxic constituents and the limited scientific evidence establishing its safety.
Medical experts also caution that homegrown comfrey and homemade herbal preparations may contain unpredictable concentrations of pyrrolizidine alkaloids, making it difficult to determine safe exposure levels.
Although historical practitioners used comfrey to treat open wounds, modern safety recommendations generally advise against applying it to damaged skin. Likewise, its longstanding association with fracture healing should not be interpreted as evidence that the herb can repair broken bones or replace established medical treatment.
The distinction between traditional reputation and scientifically demonstrated benefits remains central to evaluating comfrey.
Its allantoin and rosmarinic acid content provides a plausible biological explanation for some of the plant’s reported effects, and selected topical formulations have shown promise for relieving minor musculoskeletal discomfort. However, evidence supporting treatment of eczema, fractures and serious wounds remains insufficient.
For people considering comfrey-based products, consultation with a qualified health professional and selection of appropriately manufactured, low-alkaloid topical preparations are important precautions.
Comfrey’s history illustrates both the potential and limitations of traditional herbal medicine: a plant containing compounds of therapeutic interest can also possess significant toxicity. Current evidence supports only cautious, short-term external use of certain preparations, while ingestion remains strongly discouraged because of the risk of serious liver injury.
Original article
Comments